The University of Texas, MD Anderson Cancer Center
Houston, Texas
Naifa Busaidy is Tenured Professor at University of Texas–MD Anderson Cancer Center. Clinical & research expertise/interests are primarily focused-driven to improve outcomes in advanced thyroid carcinomas patients.
Dr. Busaidy attended Baylor College of Medicine medical school, residency and fellowship with research fellowship-UT MD Anderson to advance her clinical/research knowledge in Endocrine Tumors. She joined the UTMDACC faculty where she serves on committees & directs thyroid nodule clinic.
She serves as PI/Co-PI of NCI and industry trials with aims to identify molecular mechanisms of disease progression and targets for improving response to therapy.
She serves on NCCN Thyroid Cancer Guidelines, NCI’s PI3K/mTOR taskforce and advisory boards/consultant for oncology groups/industry to shape the treatment spectrum of thyroid cancer.
She has published extensively on thyroid cancer/Endocrine effects of cancer therapy and sits on various guidelines committees. She serves on the boards of both International Thyroid Oncology Group (ITOG) and American Thyroid Association (ATA). She also serves several endocrine societies, where she served on various committees, including: program, research grant and awards committees and is a fellow of the American Association of Clinical Endocrinology (AACE).
Exilixis (Individual(s) Involved: Self; Clinical Condition: Endocrinology): Consultant
Friday, March 18, 2022
9:00 AM – 10:45 AM
Friday, March 18, 2022
9:45 AM – 10:10 AM